578 related articles for article (PubMed ID: 26852950)
1. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.
Aristieta A; Ruiz-Ortega JA; Miguelez C; Morera-Herreras T; Ugedo L
Neurobiol Dis; 2016 May; 89():88-100. PubMed ID: 26852950
[TBL] [Abstract][Full Text] [Related]
2. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats.
Aristieta A; Ruiz-Ortega JA; Morera-Herreras T; Miguelez C; Ugedo L
Exp Neurol; 2019 Dec; 322():113036. PubMed ID: 31425688
[TBL] [Abstract][Full Text] [Related]
3. Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
McConnell GC; So RQ; Grill WM
J Neurophysiol; 2016 Jun; 115(6):2791-802. PubMed ID: 26961105
[TBL] [Abstract][Full Text] [Related]
4. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors.
Sagarduy A; Llorente J; Miguelez C; Morera-Herreras T; Ruiz-Ortega JA; Ugedo L
Exp Neurol; 2016 Mar; 277():35-45. PubMed ID: 26687972
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.
Dwi Wahyu I; Chiken S; Hasegawa T; Sano H; Nambu A
J Neurosci; 2021 Mar; 41(12):2668-2683. PubMed ID: 33563724
[TBL] [Abstract][Full Text] [Related]
6. Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.
Jin X; Schwabe K; Krauss JK; Alam M
Exp Brain Res; 2016 Apr; 234(4):1105-18. PubMed ID: 26724931
[TBL] [Abstract][Full Text] [Related]
7. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
[TBL] [Abstract][Full Text] [Related]
8. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
Park E; Song I; Jang DP; Kim IY
Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
Tseng KY; Kasanetz F; Kargieman L; Pazo JH; Murer MG; Riquelme LA
Brain Res; 2001 Jun; 904(1):93-103. PubMed ID: 11516415
[TBL] [Abstract][Full Text] [Related]
10. Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions.
Belluscio MA; Kasanetz F; Riquelme LA; Murer MG
Eur J Neurosci; 2003 Mar; 17(5):1046-52. PubMed ID: 12653980
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
[TBL] [Abstract][Full Text] [Related]
12. Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.
Keifman E; Ruiz-DeDiego I; Pafundo DE; Paz RM; Solís O; Murer MG; Moratalla R
Br J Pharmacol; 2019 Jul; 176(13):2146-2161. PubMed ID: 30895594
[TBL] [Abstract][Full Text] [Related]
13. Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states.
Lobb CJ; Jaeger D
Neurobiol Dis; 2015 Mar; 75():177-85. PubMed ID: 25576395
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata.
Vegas-Suárez S; Pisanò CA; Requejo C; Bengoetxea H; Lafuente JV; Morari M; Miguelez C; Ugedo L
Br J Pharmacol; 2020 Sep; 177(17):3957-3974. PubMed ID: 32464686
[TBL] [Abstract][Full Text] [Related]
15. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
[TBL] [Abstract][Full Text] [Related]
16. L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus.
Soghomonian JJ
Eur J Neurosci; 2006 May; 23(9):2395-403. PubMed ID: 16706847
[TBL] [Abstract][Full Text] [Related]
17. The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.
Aristieta A; Azkona G; Sagarduy A; Miguelez C; Ruiz-Ortega JÁ; Sanchez-Pernaute R; Ugedo L
PLoS One; 2012; 7(8):e42652. PubMed ID: 22880070
[TBL] [Abstract][Full Text] [Related]
18. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
[TBL] [Abstract][Full Text] [Related]
19. Dyskinesia is Closely Associated with Synchronization of Theta Oscillatory Activity Between the Substantia Nigra Pars Reticulata and Motor Cortex in the Off L-dopa State in Rats.
Chen J; Wang Q; Li N; Huang S; Li M; Cai J; Wang Y; Wen H; Lv S; Wang N; Wang J; Luo F; Zhang W
Neurosci Bull; 2021 Mar; 37(3):323-338. PubMed ID: 33210188
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
